With anti-VEGF challenger in clinic, Kodiak files for IPO

With anti-VEGF challenger in clinic, Kodiak files for IPO

Submitted by admin on September 10, 2018 - 12:19am
Source: 
BioCentury
News Tags: 
Kodiak Sciences
anti-VEGF
IPOs
Headline: 
With anti-VEGF challenger in clinic, Kodiak files for IPO
snippet: 

Ophthalmic company Kodiak Sciences Inc. (Palo Alto, Calif.) filed to raise $100 million in an IPO on NASDAQ underwritten by Morgan Stanley, BofA Merrill Lynch, Barclays and Chardan.

Do Not Allow Advertisers to Use My Personal information